Remote testing lifts Honolulu's diagnosed cancer counts

When a prevention notice airs in Marshallese or ʻŌlelo Hawaiʻi, the clinic can confirm the visit only after the tumor record shows an entry matching the broadcast date. That match is the whole test. A flyer that lifts phone traffic but never surfaces in the Pacific Regional Central Cancer Registry has proven nothing to the coalition that funded it. Buyers who commission Pacific-facing notices keep returning to one question about their spend. They want a dated screening event. A click cannot supply it.

Gomez and colleagues reported broad breast cancer increases across Asian American, Native Hawaiian, and Pacific Islander populations in the United States, with the steepest gains among women under 50. The distant-stage triple-negative and hormone receptor-negative subtypes named in the editorial climbed fastest. Their SEER analysis spanned 14 states and 9 disaggregated ethnic populations. Incidence varied more than threefold across them. Native Hawaiian women faced the heaviest burden, while rapid recent gains hit the Asian Indian, Pakistani, Chinese, Korean, and Vietnamese subgroups.

The editorial tied those patterns to migration and nativity, together with changing exposures across successive birth cohorts. Aggregation into one curve can hide risk in a community presumed to hold a low burden. It can also delay interventions built for a named subgroup. Distant-stage counts climbed in the disaggregated files as well. Gomez and colleagues warned hospital buyers against collapsing those files into one line. They argued that greater screening volume alone fails to explain the rise, which leaves room for delayed follow-up and uneven access to mammography.

A separate national cohort tells a parallel story about follow-through. Researchers examined 68,111 women aged 46 to 64 in the 2024 Behavioral Risk Factor Surveillance Survey, median age 54.8. Only 50.3% remained current on breast, cervical, and colorectal screening, a shortfall that projects to 17.9 million overdue women nationwide. Asian and Pacific Islander women showed a 14% lower likelihood of being current on all three tests than White women. A wellness visit in the past year doubled the odds of being current. Private insurance raised those odds by 54%.

The overdue pool splinters in ways worth mapping. Among those behind, 42.4% had missed more than one test. Another 3.2 million had missed all three. For women short on just one test, 58% lacked colorectal screening. Breast screening accounted for 22% of those gaps, and cervical for 20%. An estimated 8.8 million women trailed on breast screening. Of that group, 72.9% also trailed on a colorectal or cervical test. A network buying one flyer series for all three modalities cannot say which gap the flyer closed.

In Honolulu, the John A. Burns School of Medicine Pacific Cancer Programs described a comparable burden across the U.S. Affiliated Pacific Islands. About 415,000 residents occupy hundreds of islands across five time zones. Cervical cancer rates more than double the continental figure. The Republic of the Marshall Islands ranks among the highest worldwide. Most Federated States of Micronesia jurisdictions lack mammography. Chemotherapy stays unavailable across much of the region. Behind that gap, health teams rely on village visits and radio broadcasts, delivering visual inspection with acetic acid and clinical breast exams on outer islands as self-collected HPV kits gain ground.

Patients referred off-island for oncology may fly to Hawaiʻi, the continental United States, the Philippines, and Taiwan. Translation into many Pacific tongues stays difficult. One wrong word does real damage. A consent form that names mammography when the clinic booked visual inspection defeats telehealth follow-up for a Chuukese patient. Years of drafting patient-facing notices and consent forms for hospital systems keep surfacing a familiar reporting gap in client conversations. Teams fund culturally tuned flyers and radio scripts. Few of them learn whether a Marshallese flyer drove a clinic day or a Chamorro radio spot changed booking volume.

Without an uptake signal tied to the tumor record, planners cannot separate the explanations for a distant-stage trend. The rise might reflect underlying biology. It might instead reflect an access failure, with no bulletin ever matched to the appointment. A public notice can state the correct screening age band yet cite the wrong procedure code, mammography referral in place of visual inspection with acetic acid. Match the broadcast identifier to the modality logged in the central cancer file ahead of the coalition report to funders. Which entry in the island tumor file proves the campaign mattered?

Since 2004, the Cancer Council of the Pacific Islands has sustained community-led direction across the region. Its table draws clinical and public health representatives from American Sāmoa, the Commonwealth of the Northern Mariana Islands, Chuuk, Kosrae, Pohnpei, Yap, Guam, Palau, and the Marshall Islands. Screening methods became culturally owned once coalitions set the priorities themselves, ahead of any continental template. Outer-island listeners trust village radio over a clinic flyer mailed to a Honolulu post box. Reference materials that describe one aggregated low-risk profile keep an old misconception alive. The Gomez analysis had already dismantled it.

Continental campaigns still treat Asian American, Native Hawaiian, and Pacific Islander audiences as one bloc. Gomez and colleagues showed why that flattening fails the clinic. Native Hawaiian incidence patterns diverge from Vietnamese or Pohnpei needs. The local cancer profile changes from island to island. In American Sāmoa, uterine cancer incidence exceeds continental levels. Liver cancer in Palau surpasses the national average at least twofold, driven partly by obesity and hepatitis B. Yap and Pohnpei show oral cavity rates tied to betel nut use. Subgroup incidence and subtype mix should decide which notice ships in which language channel.

A breast notice built around Native Hawaiian incidence will miss what a Chuukese coalition put first, a cervical visual-inspection clinic. Priorities in Chuuk diverge from the posters drafted for Honolulu mammography campaigns. Epidemiologic files therefore need disaggregated race and ethnicity fields, harmonized across electronic health records and island cancer files, as the editorial urged. Federal investment in AANHPI clinical research has lagged for more than two decades. That neglect left sparse subgroup data and a growing multiracial classification problem. Buyers should press vendors for post-campaign uptake metrics broken out by language channel.

What the tumor record must show is a dated screening event. A click does not qualify. Link a flyer identifier to a completed screening, whether a visual-inspection clinic on an outer island or a mammography referral logged in Hawaiʻi after a patient flies in from Majuro or Kolonia. Without that link, a rising triple-negative trend looks like abstract noise while the real break in the notice chain stays hidden. JABSOM recorded more diagnosed cases once remote testing expanded. Planners then need the record to separate detection gains from true changes in incidence.

Gomez and colleagues also flagged limitations for buyers to treat as design constraints, among them rising not-otherwise-specified case codes, uncertain denominator estimation, and sparse subgroup screening data in the specialized SEER file. Those gaps shape which populations funders can see when island coalitions report to the Pacific Island Health Officers Association. Surveillance and research must share one feedback loop with clinic action. Incidence can climb even while screening expands across the region. Buyers must still prove which notice moved which modality in which jurisdiction. Without data equity, cancer equity will lag for Marshallese, Chamorro, and Native Hawaiian communities alike.